Gene · 55215
Papers1,818
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,818
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of BRIP-1 (FANCJ) and FANCI Protein Expression in Ovarian Cancer Tissue. | Biomedicines | 2024 | 39767562 | PubTator, text mining | PubMed |
| An Integrated Framework to Identify Prognostic Biomarkers and Novel Therapeutic Targets in Hepatocellular Carcinoma-Based Disabilities. | Biology (Basel) | 2024 | 39765633 | PubTator, text mining | PubMed |
| Regional Hereditary Cancer Program in Chile: A scalable model of genetic counseling and molecular diagnosis to improve clinical outcomes for patients with hereditary cancer across Latin America. | Biol Res | 2024 | 39710803 | PubTator, text mining | PubMed |
| PP2A licenses the FANCD2/FANCI complex for chromosome loading. | Cell Rep | 2024 | 39535917 | PubTator, text mining | PubMed |
| An Analysis of Genetic Polymorphisms in 76 Genes Related to the Development of Ovarian Tumors of Different Aggressiveness. | Int J Mol Sci | 2024 | 39456660 | PubTator, text mining | PubMed |
| Somatic gene mutations involved in DNA damage response/Fanconi anemia signaling are tissue- and cell-type specific in human solid tumors. | Front Med (Lausanne) | 2024 | 39421870 | PubTator, text mining | PubMed |
| The role of SUMOylation in biomolecular condensate dynamics and protein localization. | Cell Insight | 2024 | 39399482 | PubTator, text mining | PubMed |
| Multifaceted roles of SUMO in DNA metabolism. | Nucleus | 2024 | 39287196 | PubTator, text mining | PubMed |
| Pediatric Angiosarcoma with Novel Phenotypic and Genotypic Profile in Chinese Children. | Fetal Pediatr Pathol | 2024 | 39269732 | PubTator, text mining | PubMed |
| The Fanconi anemia pathway induces chromothripsis and ecDNA-driven cancer drug resistance. | Cell | 2024 | 39181133 | PubTator, text mining | PubMed |
| Genomic alterations in two patients with esophageal carcinosarcoma identified by whole genome sequencing: a case report. | Surg Case Rep | 2024 | 39158654 | PubTator, text mining | PubMed |
| Cisplatin-induced bone marrow failure in an adult patient with Fanconi anemia. | J Oncol Pharm Pract | 2024 | 39095039 | PubTator, text mining | PubMed |
| FANCD2-FANCI surveys DNA and recognizes double- to single-stranded junctions. | Nature | 2024 | 39085614 | PubTator, text mining | PubMed |
| Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation. | Mol Cancer Res | 2024 | 39083088 | PubTator, text mining | PubMed |
| Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status. | Breast Cancer Res Treat | 2024 | 39080120 | PubTator, text mining | PubMed |
| FANCI Inhibition Induces PARP1 Redistribution to Enhance the Efficacy of PARP Inhibitors in Breast Cancer. | Cancer Res | 2024 | 39037758 | PubTator, text mining | PubMed |
| Pharmacogenomic studies of fertility outcomes in pediatric cancer survivors - A systematic review. | Clin Transl Sci | 2024 | 38924306 | PubTator, text mining | PubMed |
| Benign tumors and non-melanoma skin cancers in patients with Fanconi anemia. | Fam Cancer | 2024 | 38907138 | PubTator, text mining | PubMed |
| Methylation marks in blood DNA reveal breast cancer risk in patients fulfilling hereditary disease criteria. | NPJ Precis Oncol | 2024 | 38898118 | PubTator, text mining | PubMed |
| FANCM branchpoint translocase: Master of traverse, reverse and adverse DNA repair. | DNA Repair (Amst) | 2024 | 38878565 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55215/papers?page=4